ERBB2 and breast cancer: The analysis of ECGAP SAGE showed that risk miRNAs were highly associated with breast cancer-related terms, such as “mammary gland invasive breast cancer ER+, PR+, HER2–, grade II” and “mammary gland normal breast tissue from a breast cancer patient” (Supplementary Figure S3B).